Science & Technology28 October 20265 min read
India's GM Crops Impasse: One Approval in Two Decades, a Split Supreme Court Verdict, and a Policy Vacuum That Cannot Hold
A Nobel Laureate Enters the Debate
When Richard J. Roberts, who shared the 1993 Nobel Prize in Medicine for the discovery of RNA splicing, called it "nonsense" to fear that Indian farmers would become dependent on foreign corporations by adopting genetically modified crops, he was not making a new scientific argument. He was challenging a perception that has quietly driven Indian GM crop policy for more than two decades: sovereignty anxiety dressed up as precaution. That perception helps explain why India has approved exactly one GM crop since 2002 and why the question of what comes next has landed in the Supreme Court's lap.
How India Got Here
The story begins with Bt cotton. In 2002, the government cleared its commercial cultivation through hybrids carrying the cry1Ac gene, which confers resistance to the bollworm complex. By 2006, the Genetic Engineering Appraisal Committee (GEAC) had approved Bollgard II, a second-generation version stacking two insecticidal genes. Cotton remains, to this day, the only GM crop legally cultivated in India.
The next candidate, Bt brinjal, never made it to farmers' fields. After years of contested safety reviews and sharp disagreement over the implications of foreign ownership of the underlying technology, the government imposed an indefinite moratorium in 2010. The decision was political as much as scientific, and it set the template for every subsequent GM crop proposal: delay, defer, and avoid a clear ruling.
GM mustard finally forced a reckoning. In 2024, the Supreme Court delivered a split verdict on whether the GEAC's environmental release approval for GM mustard should stand. The bench could not agree on that specific question, but it was unanimous on one point: the Centre must frame a comprehensive national policy on GM crops. That direction is the live policy question every serious aspirant should be tracking.
Understanding why the debate is so charged requires a basic grasp of what GM crops actually are. Genetic modification involves altering a plant's DNA to introduce traits such as pest resistance, herbicide tolerance, improved nutrition, or higher yield, traits that would not arise through conventional breeding alone. The techniques range from gene guns and agrobacterium-mediated transfer to microinjection and electroporation. The most discussed contemporary tool is CRISPR-Cas9, in which a guide RNA directs the Cas9 enzyme to a precise location in the genome, where it cuts the DNA strand, allowing scientists to delete, alter, or insert genetic material with far greater accuracy than older methods.
The Regulatory Architecture and Its Gaps
Environmental release of any GM crop in India requires clearance from the GEAC, which operates under the Environment Protection Act, 1986 and the 1989 Rules on the manufacture, use, import, export, and storage of hazardous microorganisms and genetically engineered organisms. Food safety dimensions are governed by the Food Safety and Standards Act, 2006, while biodiversity implications fall under the Biological Diversity Act, 2002.
On paper, this is a layered system. In practice, civil society groups have repeatedly questioned the lack of transparency in how No Objection Certificates for field trials are issued, the absence of mandatory public consultation, and the limited role of parliamentary oversight. Independent peer review of trial data is not systematically required, and published data in the public domain remains scarce.
The substantive concerns are not trivial. GM crops can trigger gene flow to native varieties, accelerating biodiversity loss and entrenching monocultures. Antibiotic resistance markers used in some GM constructs raise questions about reduced antibiotic efficacy in humans. Seed patents concentrate market power in a handful of corporations, raising input costs for farmers who may find few alternatives. Divergent GM regulations across trading partners also complicate agricultural exports, and inadequate labelling limits consumer choice.
None of these concerns is unanswerable. But answering them requires exactly what India has avoided building: a coherent, evidence-based national policy with independent oversight, transparent data, and a clear mandate for the GEAC to operate without political interference. The Supreme Court's unanimous direction in 2024 has made that avoidance harder to sustain.